Non-Invasive Prenatal Test

CQuentia offers verifi® prenatal tests to safely and non-invasively screen for the most common chromosomal abnormalities as early as 10 weeks gestation using a single maternal blood draw. Genome sequencing is the-most-advanced technique for performing noninvasive prenatal testing with excellent detection rates and a 0.1% false positive rates. Developed by illumina, the verifi® prenatal test uses whole-genome sequencing (WGS), carried out in our CLIA-certified laboratory, to screen for common fetal aneuploidies to provide accurate information for pregnant women regardless of age or risk.